1. P454The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy. (23rd April 2018) Authors: Gowran, A; Castiglioni, E; Rovina, D; Casalnuovo, F; Nigro, P; Spinelli, P; Visone, R; Rasponi, M; Redaelli, A; Pompilio, G Journal: Cardiovascular research Issue: Volume 114(2018)Supplement 1 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗